- Report
- March 2025
- 50 Pages
France
From €539EUR$600USD£462GBP
- Report
- March 2025
- 50 Pages
Mexico
From €539EUR$600USD£462GBP
- Report
- March 2025
- 50 Pages
Canada
From €539EUR$600USD£462GBP
- Report
- March 2025
- 50 Pages
United States
From €539EUR$600USD£462GBP
- Report
- February 2025
- 236 Pages
United States
From €7188EUR$7,995USD£6,162GBP
- Report
- December 2024
- 34 Pages
Canada
From €4491EUR$4,995USD£3,850GBP
- Report
- December 2024
- 31 Pages
Australia
From €4491EUR$4,995USD£3,850GBP
- Report
- December 2024
- 30 Pages
India
From €4491EUR$4,995USD£3,850GBP
- Report
- December 2024
- 31 Pages
Germany
From €4491EUR$4,995USD£3,850GBP
- Report
- November 2024
- 750 Pages
Global
From €1798EUR$2,000USD£1,542GBP
- Report
- November 2024
- 750 Pages
Global
From €1798EUR$2,000USD£1,542GBP
- Report
- October 2024
- 216 Pages
Global
From €3596EUR$4,000USD£3,083GBP
- Report
- September 2024
- 117 Pages
Global
From €4046EUR$4,500USD£3,468GBP
- Report
- May 2024
- 142 Pages
Global
From €3596EUR$4,000USD£3,083GBP
- Report
- February 2024
- 158 Pages
Global
From €4181EUR$4,650USD£3,584GBP
- Report
- January 2024
- 315 Pages
Global
From €3147EUR$3,500USD£2,698GBP
- Report
- January 2024
- 120 Pages
United States
€3147EUR$3,500USD£2,698GBP
- Report
- November 2023
- 130 Pages
Global
From €1753EUR$1,950USD£1,503GBP
- Report
- August 2023
- 1300 Pages
Global
From €8002EUR$8,900USD£6,860GBP
- Report
- August 2023
- 51 Pages
South Korea
From €539EUR$600USD£462GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more